Category: <span>Mesothelioma News</span>

Study Begins to Develop Breath Test for Mesothelioma Early Detection

As an occupational medicine specialist for more than 30 years, Dr. Michael Harbut has spent much of his career combating asbestos-related disease. Rarely has he felt this energized. Harbut is the lead investigator in a new, high-tech study of breath-based biomarkers that could save lives through novel, early detection of mesothelioma cancer. “This study has…

The post Study Begins to Develop Breath Test for Mesothelioma Early Detection appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Long-Term 9/11 Funding Bill Moves Closer to Reality

The House Judiciary Committee passed the Never Forget the Heroes bill Wednesday that will extend the 9/11 Victim Compensation Fund until 2090. The bill would ensure all victims of the Sept. 11 terrorist attacks — and their families — will be compensated throughout their lives. It now must pass the full House of Representatives and…

The post Long-Term 9/11 Funding Bill Moves Closer to Reality appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma Patients Not Receiving Treatment Impacts Guidelines and Overall Survival

A mesothelioma diagnosis can be grim and have life-long impact on the patients and family. The aggressive nature and the late diagnosis of the disease make it difficult to treat. The average life expectancy after initial diagnosis is on average one year, but with treatment – especially multimodality treatments – patients can live much longer.

more

Study Combines PD-1 and CAR-T Immunotherapy to Treat Mesothelioma

At the 2019 American Society of Clinical Oncology annual meeting, Dr. Prasad Adusumilli from Memorial Sloan Kettering Cancer Center shared exciting new results from his study on combination immunotherapy for malignant pleural mesothelioma. Among the 18 mesothelioma patients in the study, 14 received a combination of two different immunotherapy treatments. Eleven of this group experienced…

The post Study Combines PD-1 and CAR-T Immunotherapy to Treat Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

FDA Finds Asbestos in More Claire’s Makeup Products

Popular tween store Claire’s has once again been found creating products for children that contain asbestos. The store first came under fire in 2017, when the U.S. Food and Drug Administration (FDA) confirmed the presence of the toxin in three Claire’s products, as well as several products from Justice, another tween and children’s store. At the time, Claire’s pulled the products from the shelves, but denied all reports that asbestos had been found in their makeup. In a company statement, they reasoned, “All our powder-based cosmetics use the same base formulation, utilizing Merck certified asbestos-free talc, which is the same talc used in other well-known cosmetic brands.”

Mesothelioma Treatment Guidelines Not Followed Often Enough

Too many patients with pleural mesothelioma are going without treatment recommended by National Comprehensive Cancer Network guidelines, according to a recent study at Cedars-Sinai Medical Center in Los Angeles. Valuable survival time is being lost. The Annals of Thoracic Surgery published the study that looked at disparities in compliance with national treatment guidelines and their…

The post Mesothelioma Treatment Guidelines Not Followed Often Enough appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Claire’s Recalls JoJo Siwa Makeup over Asbestos Contamination

For the second time in three months, Claire’s stores issued a voluntary recall over concerns of asbestos contamination in its makeup products marketed to young girls, the U.S. Food and Drug Administration announced late Thursday. Claire’s, a children’s fashion accessory retail chain found in malls across the U.S., has recalled its JoJo Siwa Makeup Set…

The post Claire’s Recalls JoJo Siwa Makeup over Asbestos Contamination appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Study Finds Modest Reality of Immunotherapy for Cancer

Less than 13% of cancer patients who receive checkpoint inhibitor drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) actually benefit from the much-heralded form of immunotherapy, new research shows. The modest response rate is part of the first broad study that has estimated the rise in patient eligibility and the actual benefit of this immunotherapy…

The post Study Finds Modest Reality of Immunotherapy for Cancer appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Johnson & Johnson Hit with $325M Verdict in Talc-Mesothelioma Case

A state jury in New York ordered Johnson & Johnson to pay $300 million in punitive damages to Donna Olson and her husband who claim its talcum powder caused her to develop mesothelioma. The same jury awarded the couple $25 million in compensatory damages a few days earlier. The total verdict is one of the…

The post Johnson & Johnson Hit with $325M Verdict in Talc-Mesothelioma Case appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

First FDA Approved Treatment for Mesothelioma in 15 Years

In the Fall of 2018 scientists and researchers from Novocure, an oncology company that specializes in treating solid tumors, were hopeful their latest success with Tumor Treating Fields therapy would lead to FDA approval and ultimately, more options for those suffering from mesothelioma. After a successful clinical trial, these hopes became a reality as the

more

FDA Approves New Mesothelioma Treatment for the First Time in 15 Years

Malignant mesothelioma is an aggressive disease that is most often diagnosed in the later stages, at stage 3 or stage 4. Late-stage diagnoses limit treatment options for the patient, typically eliminating the possibility of radical surgeries. Multimodal therapy is the most common treatment for mesothelioma cancer, consisting of a combination of surgery, chemotherapy, and/or radiation. The possibility of multimodal therapy or what combination is used depends on a case-by-case basis.

FDA Approves First New Treatment for Mesothelioma in 15 Years

The U.S. Food & Drug Administration on Thursday approved Tumor Treating Fields, a therapy involving electric currents that disrupt cancer cell division and inhibit tumor growth, for the first-line treatment of malignant pleural mesothelioma. It is the first treatment in more than 15 years that the FDA approves for mesothelioma. In 2004, the agency added…

The post FDA Approves First New Treatment for Mesothelioma in 15 Years appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Fall 2019 Scholarship Winner Karina Stiles-Cox

Mesothelioma.com is pleased to announce the winner of the Fall 2019 Scholarship, Karina Stiles-Cox.
This fall, Karina will begin pursuing her doctorate in humanities at Salve Regina University. As Karina explained in her essay, the dream of earning her PhD has been many years in the making and has been derailed numerous times from hardships she has faced, including her breast cancer diagnosis.